2000
DOI: 10.1046/j.1471-4159.2000.0740001.x
|View full text |Cite
|
Sign up to set email alerts
|

Apoptosis and the Nervous System

Abstract: Abstract:Apoptosis is now recognized as a normal feature in the development of the nervous system and may also play a role in neurodegenerative diseases and aging. This phenomenon has been investigated intensively during the last 6 -7 years, and the progress made in this field is reviewed here. Besides a few in vivo studies, a variety of neuronal preparations from various parts of the brain, the majority of which were primary cultures, and some cell lines have been investigated. Several apoptosis-inducing agen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
231
0
6

Year Published

2000
2000
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 409 publications
(242 citation statements)
references
References 205 publications
(312 reference statements)
5
231
0
6
Order By: Relevance
“…Recently, we have found that administration of the cyclooxygenase-2 inhibitor nimesulide at a dose proven to confer protection in the present study (6 mg/kg), is able to reduce hippocampal oxidative damage following excitotoxic brain injury (Candelario-Jalil et al, 2000), which is a key pathological event of cerebral ischemia. This latter observation is particularly relevant in view of evidence showing that oxidative stress is implicated in the development and progression of apoptotic cell death in the central nervous system (Sastry and Rao, 2000) and that activation of cyclooxygenase-2 is required for execution of oxidative neuronal death (Lee et al, 2001). Further experiments are needed to clarify the effects of selective inhibition of cyclooxygenase-2 on markers of oxidative stress in the ischemic brain and its relation to neuronal death after ischemia.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, we have found that administration of the cyclooxygenase-2 inhibitor nimesulide at a dose proven to confer protection in the present study (6 mg/kg), is able to reduce hippocampal oxidative damage following excitotoxic brain injury (Candelario-Jalil et al, 2000), which is a key pathological event of cerebral ischemia. This latter observation is particularly relevant in view of evidence showing that oxidative stress is implicated in the development and progression of apoptotic cell death in the central nervous system (Sastry and Rao, 2000) and that activation of cyclooxygenase-2 is required for execution of oxidative neuronal death (Lee et al, 2001). Further experiments are needed to clarify the effects of selective inhibition of cyclooxygenase-2 on markers of oxidative stress in the ischemic brain and its relation to neuronal death after ischemia.…”
Section: Discussionmentioning
confidence: 99%
“…To date, a number of neuronal cell culture models that were treated with different apoptotic agents such as protein S100B, cytokines, 3,4-methyl-enedioxy-methamphetamine or NO donors, show that the cells undergo apoptosis with the formation of NO (31). NO can release cytochrome C from mitochondria (32) and the apoptotic mechanism includes caspase-3 activation following down-regulation of Bcl-2 and up-regulation of Bax protein levels (33).…”
Section: Discussionmentioning
confidence: 99%
“…Altered lipid metabolism is believed to contribute to cerebral ischemic injury. [21][22][23][24][25][26][27][28][29][30][31][32] Lipidomics holds the promise of characterizing complex mixtures of lipids, identifying previously unknown changes in lipid metabolism, and opening new opportunities for drug development. 33 …”
Section: Focal Cerebral Ischemia (Stroke)mentioning
confidence: 99%